Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cleveland Biolabs (CBLI)

Cleveland Biolabs (CBLI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,834
  • Shares Outstanding, K 11,298
  • Annual Sales, $ 1,140 K
  • Annual Income, $ -3,610 K
  • 60-Month Beta 0.65
  • Price/Sales 14.59
  • Price/Cash Flow N/A
  • Price/Book 6.02

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.45 +2.76%
on 07/17/19
1.68 -11.31%
on 06/27/19
-0.06 (-3.87%)
since 06/19/19
3-Month
1.40 +6.43%
on 04/23/19
1.79 -16.76%
on 04/23/19
-0.02 (-1.32%)
since 04/18/19
52-Week
1.00 +49.00%
on 01/02/19
3.16 -52.85%
on 07/31/18
-0.80 (-34.93%)
since 07/19/18

Most Recent Stories

More News
Cleveland Biolabs Reports First Quarter 2019 Financial Results and Development Progress

today reported financial results and development progress for the first quarter ended March 31, 2019.

CBLI : 1.49 (+1.36%)
Report: Exploring Fundamental Drivers Behind Chimera Investment, Virtu Financial, Cleveland BioLabs, and Art's-Way Manufacturing Co. -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Chimera Investment Corporation...

CBLI : 1.49 (+1.36%)
CIM : 19.12 (-0.10%)
ARTW : 2.11 (+4.98%)
VIRT : 21.99 (+0.09%)
Cleveland Biolabs Reports 2018 Financial Results and Development Progress

today reported financial results and development progress for the fourth quarter and year ended December 31, 2018.

CBLI : 1.49 (+1.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CBLI with:

Business Summary

CLEVELAND BIOLABS, INC. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic, Roswell Park...

See More

Key Turning Points

2nd Resistance Point 1.49
1st Resistance Point 1.49
Last Price 1.49
1st Support Level 1.49
2nd Support Level 1.49

See More

52-Week High 3.16
Fibonacci 61.8% 2.33
Fibonacci 50% 2.08
Fibonacci 38.2% 1.83
Last Price 1.49
52-Week Low 1.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar